Status:
COMPLETED
Serum Concentration of Lidocaine After Local Injection During Mohs Micrographic Surgery
Lead Sponsor:
Northwestern University
Conditions:
Basal Cell Carcinoma
Squamous Cell Carcinoma
Eligibility:
All Genders
18-75 years
Brief Summary
The primary objective of this study is to (1) determine whether local injection of lidocaine used during Mohs surgery will elevate serum lidocaine concentrations to a level that could cause systemic s...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Age: 18-75
- Basal cell carcinoma or squamous cell carcinoma of the head or neck
- Subjects are in good health
- Subjects that have the willingness and the ability to understand and provide informed consent for the use of their blood and communicate with the investigator
- Exclusion Criteria
- Lidocaine sensitivity
- Bleeding disorder
- Pregnancy
- Medical conditions which would impair hepatic blood flow: congestive heart failure, liver dysfunction, peripheral vascular disease.
- Subjects who are unable to understand the protocol or to give informed consent
- Subjects with mental illness
Exclusion
Key Trial Info
Start Date :
September 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2008
Estimated Enrollment :
19 Patients enrolled
Trial Details
Trial ID
NCT00793169
Start Date
September 1 2007
End Date
July 1 2008
Last Update
December 6 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Northwestern University
Chicago, Illinois, United States, 60611